Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
Design and implementation of the multi-arm, multi-stage Therapeutics for Inpatients with COVID-19 (TICO) platform master protocol: An Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative.
The Aging Imageomics Study: rationale, design and baseline characteristics of the study population.
The EuroSIDA study: 25 years of scientific achievements.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients.
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping.